Clinical trial
Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.
NCT01796691 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.
- Lead sponsor
- Ruhr University of Bochum
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- February 28, 2013
- Enrollment
- 600 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.